Provide fertility benefits solutions for employers. Offer personalized concierge-style member support services. Now — the numbers.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
This is an established company with proven profits.
Average growth of 27% a year over the last 4 years. Every year shown ended in profit.
If every debt were paid off today, $282.4M would still be left in the vault — a solid cushion for hard times.
The market pays 34.6× for every dollar this company earns in a year — a price that already assumes things go well.
Against companies in its own sector, it looks cheaper than 85% of them.
Analysts' average target sits 36% above today's price.
Executive selling isn’t always bad news; people sell for personal reasons too. Still, the thin buying side is worth noting.
An investor who bought at the very peak is down 61% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 4 years, sales grew about 27% a year on average.
There is $310.1M in the vault; even if every debt were paid off, $282.4M would remain.
The company’s market value is 35 times its annual profit. Even a small disappointment could hit the price hard.
Since the drop from its peak, buyer appetite hasn’t come back.
Costs swallow the gains that sales growth brings in.
On our five-subject report card, PGNY sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: PGNY is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.